Rx Innovation: A Discussion on Biosimilars, Patient Access & Affordability
TIME / DATE
Dec 4 8:00 AM - 10:00 AM, 2014
Express Scripts research shows that the U.S. would save $250 billion between 2014 and 2024, with the approval of just 11 biosimilar drugs. The Hill will host a conversation exploring the potential cost savings of biosimilars, FDA approval processes for new medicines and the state of the industry worldwide.